PT  - JOURNAL ARTICLE
AU  - Nichols, Emma Hitt
ED  - Middleton, Gary W.
TI  - Targeting Telomerase with GV1001 Vaccine Does Not Prolong OS in Advanced Pancreatic Cancer
DP  - 2013 Aug 01
TA  - MD Conference Express
PG  - 22--22
VI  - 13
IP  - 6
4099  - http://mdc.sagepub.com/content/13/6/22.1.short
4100  - http://mdc.sagepub.com/content/13/6/22.1.full
AB  - Sequential or concurrent treatment with the vaccine GV100 with chemotherapy does not result in a survival advantage in patients with advanced pancreatic cancer. This article discusses data from the fourth interim analysis of the Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer study [TeloVac; NCT00425360; Middleton GW et al. J Clin Oncol 2013 (suppl; abstr LBA4004)].